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In Brief Stender et al. show that positron emission tomography measurement of whole-brain glucose metabolic state allows accurate diagnosis and prediction of disorders of consciousness. Recovery from the unresponsive wakefulness condition occurs above a sharply defined brain metabolic limit, reflecting the minimal energetic requirements of consciousness.
SUMMARY
Differentiation of the minimally conscious state (MCS) and the unresponsive wakefulness syndrome (UWS) is a persistent clinical challenge [1] . Based on positron emission tomography (PET) studies with [ 18 F]-fluorodeoxyglucose (FDG) during sleep and anesthesia, the global cerebral metabolic rate of glucose has been proposed as an indicator of consciousness [2, 3] . Likewise, FDG-PET may contribute to the clinical diagnosis of disorders of consciousness (DOCs) [4, 5] . However, current methods are non-quantitative and have important drawbacks deriving from visually guided assessment of relative changes in brain metabolism [4] . We here used FDG-PET to measure resting state brain glucose metabolism in 131 DOC patients to identify objective quantitative metabolic indicators and predictors of awareness. Quantitation of images was performed by normalizing to extracerebral tissue. We show that 42% of normal cortical activity represents the minimal energetic requirement for the presence of conscious awareness. Overall, the cerebral metabolic rate accounted for the current level, or imminent return, of awareness in 94% of the patient population, suggesting a global energetic threshold effect, associated with the reemergence of consciousness after brain injury. Our data further revealed that regional variations relative to the global resting metabolic level reflect preservation of specific cognitive or sensory modules, such as vision and language comprehension. These findings provide a simple and objective metabolic marker of consciousness, which can readily be implemented clinically. The direct correlation between brain metabolism and behavior further suggests that DOCs can fundamentally be understood as pathological neuroenergetic conditions and provide a unifying physiological basis for these syndromes.
RESULTS

Positron emission tomography (PET) studies with [
18 F]-fluorodeoxyglucose (FDG) suggest that impaired consciousness following brain injury is associated with overall brain metabolic levels of 40%-60% of normal in conditions of coma, unresponsive wakefulness syndrome (UWS), and minimally conscious state (MCS) [5, 6] . Notwithstanding, relative regional variations in metabolism correlate with the preservation of specific behavioral or perceptual functions in MCS patients [7, 8] , supporting the claim that network activations cause local increases in energy metabolism even in disorders of consciousness (DOCs) [9] . Although assessment of relative cerebral metabolic patterns with FDG-PET is a sensitive diagnostic tool in DOCs, current methods are non-quantitative and inherently examiner dependent. The development of diagnostic markers based on quantitative measures of brain metabolism would enable a more objective method for diagnosing DOCs, but they necessitate the establishment of absolute energetic requirements of awareness. However, no absolute cerebral metabolic criteria exist that allow to distinguish between MCS and the more severe UWS [1, 6] , mainly because the presence of severe brain pathology interferes with conventional non-invasive quantification methods. We therefore employed a method of FDG uptake normalization relative to extracerebral tissue, developed specifically to accommodate difficulties in PET imaging of severe brain injury patients. We hypothesized that global glucose metabolic activity predicts the capacity for maintenance of conscious awareness, while its regional variations reflect the integrity of specific perceptual or cognitive functions. We also test the hypothesis that the global cerebral metabolic rate predicts the preservation or reattainment of consciousness at 1-year follow-up. FDG-PET data at rest were acquired in 131 DOC patients and 28 healthy controls ( Table 1) . The patient population was split into independent cohorts for derivation and validation of the diagnostic model (Table S1 ). PET images were normalized to signal intensity in the extracerebral cephalic tissue, which is unaffected by brain injury and stable across subjects, thus yielding a pseudo-quantitative cerebral metabolic index. To perform the normalization, a reference distribution was calculated from the extracerebral tissue intensity distributions of the 28 control subjects. Each individual image of the study population was subsequently normalized, by selecting a global scaling factor of the image intensity such that the Jensen-Shannon divergence between the reference distribution and the subject's extracerebral intensity distribution was minimized [10] . Metabolic activity after normalization was assigned an index value, with average extracerebral metabolism in the reference distribution set to one (see Supplemental Experimental Procedures). Brain images were then first segmented into entire cerebral cortex of left and right hemispheres and then further according to Brodmann areas (BA) (Supplemental Experimental Procedures). We extracted the mean cortical FDG uptake in each hemisphere and BA volumes of interest (VOIs). We used the mean cortical metabolism of the best preserved hemisphere (with highest mean cortical metabolism prior to lesion masking) to classify between UWS and MCS and predict outcome at 1-year follow-up, using receiver operating characteristic (ROC) analysis.
Global Glucose Metabolism Rate as Diagnostic Marker
Mean cortical metabolic index was 7.59 ± 1.19 in healthy controls, 2.88 ± 0.74 (38% of normal) in UWS, 4.23 ± 1.03 (56% of normal) in MCS, and 4.76 ± 0.65 (63% of normal) in emergence from MCS (EMCS). See Figure 1 for individual patient examples. One-way ANOVA with Bonferroni correction for three comparisons showed that average metabolic rates were significantly higher in MCS than UWS (p < 0.001) and in healthy controls compared to EMCS (p < 0.001), but not in EMCS compared to MCS (p = 0.098). Metabolic rates were not influenced by any of a range of possible confounders, including age, etiology, time since onset, and use of sedation during imaging (Supplemental Experimental Procedures).
Average cortical glucose metabolism gave diagnostic discrimination between MCS and UWS at an area under the ROC-curve (AUC) of 0.84 (confidence interval [CI] 0.67-1) in the derivation cohort and 0.91 (CI 0.84-0.98) in the validation cohort. The performance of the classifier did not significantly differ between the two cohorts (p = 0.45). The best classification rate in the derivation cohort was achieved at a metabolic index of 3.17 (41% of normal activity; Figure 2 ), resulting in 89% correct classification between UWS and MCS, with 95% sensitivity and 79% specificity to MCS, thus satisfying reasonable requirements for a clinically useful diagnostic criterion. In the validation cohort, this diagnostic threshold provided an 87% correct classification rate between UWS and MCS, with 95% sensitivity and 77% specificity to MCS. Post hoc inference suggested an optimal metabolic cutoff at a metabolic index of 3.19 (42% of normal) in the validation cohort; all patient classifications at this level remained unchanged compared to the derivation cohort threshold, i.e., performance of the diagnostic model was similar in the derivation and validation cohorts ( Table 2) .
Diagnostic accuracy with the above diagnostic criterion provided an AUC of 0.89 across the pooled cohort (CI 0.82-0.96). There was 88% correct classification between MCS and UWS, with 95% sensitivity and 78% specificity to MCS. Every EMCS patient and healthy control was correctly identified as conscious.
Outcome Prediction
Outcome data at 1-year follow-up were obtained for 91% of the patients. Demographic and clinical data did not differ between patients with known outcome data and those without follow-up data. Group discrimination by the metabolic criterion correctly predicted 88% of all known patient outcomes, with 95% sensitivity and 76% specificity to manifest consciousness at followup ( Figure 2 ; Table S3 ). A total of 11 UWS patients had brain metabolism above the 41% diagnostic threshold. Of these, eight had recovered consciousness at follow-up, and the remaining three had died. One UWS patient with sub-threshold metabolism progressed to MCS on follow-up. Of the three MCS patients with sub-threshold metabolism, one died, while another one had no change of clinical condition. The third patient was lost to follow-up ( Figure 2 ).
Regional Metabolic Activity
No specific regional drivers of the patients' condition could be identified, as the metabolic group differences were present in all VOIs (Figure 3 ). Relative regional variability around the mean activity was low, with interregional coefficients of variance (SD/mean) of 6% in UWS, 13% in MCS, 14% in EMCS, and 15% in controls.
FDG uptake in peristriate visual cortex (BA 18) had the highest individual regional classification rate across the pooled cohort, with an AUC of 0.90. This value, however, did not differ significantly from the overall hemispheric classification rate (0.89; p = 0.11). BA 18 classification rate (86%), sensitivity to MCS (94%), and outcome prediction (80%) were slightly inferior to classification by the entire hemisphere.
In order to test the hypothesis that regional variations relative to the resting baseline metabolism can reflect preservation of specific cognitive and sensory functions, we first normalized all images to their global best-hemisphere mean (GM). Next, we calculated Pearson correlation coefficients between visual awareness, defined by the Coma Recovery Scale-Revised (CRS-R) as the capacity for visual tracking, and GM normalized activity and absolute mean activity within visual cortex BAs 17, 18, and 19. Along the same line, we tested whether the ability to respond to verbal commands correlated with GM-normalized activity as well as absolute mean activity in areas commonly associated with receptive aphasia, i.e., the left primary and secondary auditory cortices (BAs 20-22) and Wernicke's area (BAs 39 and 40). Only MCS patients were included in this analysis. The presence of visual responsiveness correlated with GM-normalized metabolic rate in the visual cortex (r = 0.24, p = 0.028), but not with absolute metabolic rates (r = 0.12, p = 0.29). Capacity for command following correlated with both GM-normalized and extracerebral normalized metabolic index in the auditory and language-related areas (r = 0.49, p < 0.0001 and r = 0.39, p = 0.002, respectively).
DISCUSSION
We tested the capacity of FDG-PET to diagnose the presence and to predict the recovery of consciousness in brain-injured subjects, using a novel measure of cerebral metabolic activity based on extracerebral tissue normalization. The model accuracy was determined in two independent cohorts, using both behavioral diagnosis and outcome at 1-year follow-up as references. We show that our index of cerebral metabolic activity differentiates accurately between UWS and MCS patients, hence providing a strong diagnostic and prognostic marker for chronic DOCs.
Global Cortical Metabolism as Predictor of Consciousness
We hypothesized that the average cortical metabolic activity in the most intact cerebral hemisphere can be used to classify patients suffering from chronic DOCs. As large lateralized cerebral lesions are prevalent in this population and may selectively impair functioning of the affected hemisphere [11] , global mean metabolic activity is a poor representation of preserved cerebral function. Since there is ample evidence that conscious awareness can be maintained with only one hemisphere [12, 13] , we reasoned that an FDG-PET index of glucose metabolism of the least injured cortical hemisphere would be a better indicator of consciousness than is whole-brain cortical activity. This prediction was confirmed by our finding that mean glucose metabolism index in the best preserved hemisphere is an accurate subject-level diagnostic marker and that no individual brain region provided better classification than the average cortical signal. The diagnostic performance of this method was equally good in the derivation and validation samples, indicating that the method is valid across independent cohorts. ROC of the classification between MCS and UWS gave a common ''optimal'' diagnostic threshold of 42% of normal metabolic activity, resulting in excellent sensitivity and adequate specificity to MCS. Moreover, all EMCS patients and healthy controls were correctly identified as being conscious. We conclude that this FDG-PET diagnostic threshold provides reliable differentiation between conscious and unconscious subjects, with a good balance between type I and type II error risks.
The FDG metabolic index in the MCS groups largely overlapped with that in EMCS and was in a few cases within the range of healthy control values. This is not surprising given the fluctuating severity of MCS. Also, the mean cortical glucose metabolic index was not dependent on etiology or any of the potential confounders such as age or gender. Together, these results suggest that cerebral glucose metabolism is strongly linked to the expression of consciousness, irrespective of cause of injury and time since onset. Cerebral metabolic activity also accurately predicted the level of consciousness at 1-year follow-up. Group separation along the 42% diagnostic threshold had an overall 88% correct outcome prediction in the mixed group of MCS and UWS patients. This is all the more compelling considering that the relatively high mortality rate over the long follow-up period may have attenuated the predictive power. Nonetheless, our method correctly predicted eight out of ten recoveries among UWS patients. The specificity of the metabolic level to both diagnosis and prognosis suggests that the classification threshold represents the minimal energetic requirements of sustained awareness. Notably, our results indicate that transition between the unconscious and conscious states takes place above a sharply defined global (or hemispheric) metabolic boundary and point to a global energetic threshold effect, which enables the reemergence of consciousness after brain injury. This finding is consistent with previous propositions [2, 14] that consciousness cannot solely be attributed to activity in specific networks or areas but is associated with a whole-brain high energetic state. As such, preserved glucose metabolic rate in at least one hemisphere appears a necessary (but not sufficient) condition to regain awareness af- 
Significance of Regional Metabolic Variations Relative to the Cortical Hemispheric Average
All subjects had regional cerebral metabolic variations relative to the global mean signal. Brain activation in response to specific sensory or cognitive tasks can cause 10%-30% local increases in the magnitude of cortical glucose metabolism relative to resting baseline [9] . We reasoned that regions of relatively spared glucose metabolism in our patient groups reflect sustained activity in support of specific cognitive or sensory functions. Thus, while all conscious groups showed interregional variations with a coefficient of variance of 13%-15%, i.e., within the range of the proposed modular activation effect, glucose metabolic activity was nearly uniform across all cortical regions in UWS patients. Regional metabolic patterns in the MCS and EMCS groups were qualitatively similar to that observed in normal subjects, i.e., relatively higher in primary sensorimotor areas, although the peaks had lower absolute values and less variability. This pattern differs substantially from that of UWS patients, which was characterized by overall low FDG uptake, and is accordingly associated with capacity for consciousness. Our previous findings of relatively lowered frontoparietal metabolism in UWS patients [4, 6] can therefore be explained by the absence of regional activations rather than by a specific decline or injury to these areas.
MCS patients with absence of overt visual awareness had relatively lower activity in visual cortex, further supporting the functional relevance of regional variations in residual metabolism. Conversely, these patients' ability of command responding correlated with FDG uptake in auditory and language areas. Notably, these correlations emerged or became stronger after global mean scaling and therefore indicate relative preservation of energy metabolism in regions subserving preserved cognitive domains. Thus, with the global effect accounted for, specific regional differences between unconscious and conscious patients largely appear to reflect preserved sensory or cognitive capacity.
Clinical Implementation
The results indicate that assessment of cortical glucose metabolism by non-invasive FDG-PET is a reliable method for detecting the presence of, or potential for, consciousness and cognition after brain injury. The method is objective and computationally simple and provides easily interpretable results. Overall, this represents an important improvement to current non-quantitative diagnostic approaches with FDG-PET.
Study Limitations
We here assume a direct correlation between the metabolic index and actual neuronal work. The accuracy of this assumption should be evaluated in further studies (but see Supplemental Experimental Procedures for supporting data). The present study was cross-sectional and did not allow evaluation of rapid evolution of metabolic status or their potential effects on clinical outcome. While we cannot attribute causation in the link between high brain glucose metabolism and conscious awareness, the FDG-PET literature on anesthesia [2, 3] suggests causation. We could not assess possible contributions of cerebral morbidity prior to injury, nor did we consider the normal declines in cerebral metabolism between childhood and adolescence [15] and further into old age [16] .
The method requires high standards in image quality and registration. Current atlas-based approaches cannot precisely describe subcortical changes in severely deformed brains [17] . Investigations of subcortical metabolic drivers, such as thalamo-cortical [18] or mesocircuit loops [19] , therefore fall outside the scope of this study.
Conclusions
Hemispheric preservation of brain glucose metabolism predicts the presence, or potential for recovery, of consciousness in brain injury patients. Loci of regionally preserved metabolism subserve specific cognitive and sensory functions. The threshold of 42% of normal cortical hemispheric metabolic activity represents the minimal energetic requirement predictive of regaining consciousness. FDG-PET thus constitutes a strong diagnostic and prognostic marker in DOC arising from brain injury, irrespective of its pathogenesis.
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